Ph.D. pharmaceutical economics and policy, M.S., pharmaceutical economics and policy and neuroscience, University of Southern California; Bachelor of Medicine, Shanghai Medical Center, Fudan University
Summary of Experience
Dr. Zhou specializes in health economics and outcomes research. She has extensive experience conducting comparative-effectiveness and cost-effectiveness research using clinical trial and real-world data, health technology assessments in US and global markets, retrospective claim analysis, and health outcomes research using advanced statistical methods. This research has involved a variety of disease areas, including several cancers, bleeding disorders, mental health disorders, cardiovascular diseases, and infectious diseases. In her work with health technology assessment agencies – such as UK NICE, Canada CADTH, and Germany IQwiG – Dr. Zhou has led the submissions of systematic literature reviews and economic models. Her work has been published in many peer-reviewed journals and featured at numerous conferences.
Healthcare Resource Use, Costs, and Disease Progression Associated with Diabetic Nephropathy in Adults with Type 2 Diabetes: A Retrospective Observational Study
Diabetes Therapy. Jun 2017;8(3):555-571